CY1115599T1 - 6,7,8,9-tetrahydro-pyrimidine derivatives {1,2-a} PYRIMIDIN-4-ONE, THEIR PREPARATION AND THE PHARMACEUTICAL USE - Google Patents

6,7,8,9-tetrahydro-pyrimidine derivatives {1,2-a} PYRIMIDIN-4-ONE, THEIR PREPARATION AND THE PHARMACEUTICAL USE

Info

Publication number
CY1115599T1
CY1115599T1 CY20141100668T CY141100668T CY1115599T1 CY 1115599 T1 CY1115599 T1 CY 1115599T1 CY 20141100668 T CY20141100668 T CY 20141100668T CY 141100668 T CY141100668 T CY 141100668T CY 1115599 T1 CY1115599 T1 CY 1115599T1
Authority
CY
Cyprus
Prior art keywords
pyrimidin
tetrahydro
preparation
pharmaceutical use
pyrimidine derivatives
Prior art date
Application number
CY20141100668T
Other languages
Greek (el)
Inventor
Eric Bacque
Maurice Brollo
Annie Clauss
Youssef El-Ahmad
Bruno Filoche-Rommé
Frank Halley
Karl Andreas Karlsson
Gilbert Marciniak
Baptiste Ronan
Laurent Schio
Bertrand Vivet
Fabrice Viviani
André Zimmermann
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0903237A external-priority patent/FR2947551B1/en
Priority claimed from FR0957069A external-priority patent/FR2951174B1/en
Priority claimed from EP10742013.5A external-priority patent/EP2448940B1/en
Application filed by Sanofi filed Critical Sanofi
Publication of CY1115599T1 publication Critical patent/CY1115599T1/en

Links

Abstract

Η εφεύρεση αφορά σε νέα προϊόντα με τον τύπο (Ι) στον οποίο το R1 αντιπροσωπεύει το L-αρύλιο ή το L-ετεροαρύλιο που είναι ενδεχομένως υποκατεστημένα, έτσι ώστε το L αντιπροσωπεύει έναν απλό δεσμό, αλκύλιο, CO, ή CΟ-alk όπου το L'-Χ με το L' αντιπροσωπεύει το αλκύλιο και το Χ αντιπροσωπεύει το Ο ή το S, το R2 αντιπροσωπεύει το Η ή το αλκύλιο, το R3 αντιπροσωπεύει το αλκύλιο που είναι ενδεχομένως υποκαστεστημένο με Hal, το R4 αντιπροσωπεύει το Η ή το Ηal, όπου τα προϊόντα αυτά βρίσκονται σε όλες τις μορφές των ισομερών και των αλάτων, ως φάρμακα.The invention relates to novel products of formula (I) in which R1 represents L-aryl or L-heteroaryl optionally substituted, such that L represents a single bond, alkyl, CO, or CO-alk where L'-X with L 'represents alkyl and X represents O or S, R2 represents H or alkyl, R3 represents alkyl optionally substituted with Hal, R4 represents H or Hal , where these products are found in all forms of isomers and salts, as medicines.

CY20141100668T 2009-07-02 2014-08-20 6,7,8,9-tetrahydro-pyrimidine derivatives {1,2-a} PYRIMIDIN-4-ONE, THEIR PREPARATION AND THE PHARMACEUTICAL USE CY1115599T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0903237A FR2947551B1 (en) 2009-07-02 2009-07-02 NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A) PYRIMIDIN-6-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB)
US24109809A 2009-09-10 2009-09-10
FR0957069A FR2951174B1 (en) 2009-10-09 2009-10-09 NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A} PYRIMIDIN-6-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB)
EP10742013.5A EP2448940B1 (en) 2009-07-02 2010-07-01 6,7,8,9-tetrahydro-pyrimido{1,2-a} pyrimidin-4-one derivatives, their preparation and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
CY1115599T1 true CY1115599T1 (en) 2017-01-04

Family

ID=58461632

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100668T CY1115599T1 (en) 2009-07-02 2014-08-20 6,7,8,9-tetrahydro-pyrimidine derivatives {1,2-a} PYRIMIDIN-4-ONE, THEIR PREPARATION AND THE PHARMACEUTICAL USE

Country Status (1)

Country Link
CY (1) CY1115599T1 (en)

Similar Documents

Publication Publication Date Title
CY1118735T1 (en) BENZIMIDAZOL-PROLINE PRODUCTS
CY1119442T1 (en) 2,3-Dihydro-1H-imidazo {1,2-A} PYRIMIDIN-5-ONE PRODUCTION, PREPARATION OF THESE AND PHARMACEUTICAL USE
CY1117956T1 (en) N3-REPLACED-N1-SULFONYL-5-FLUOROPYRIMIDINONE PRODUCT
CY1117374T1 (en) IMIDAZOPYRIDINE PRODUCTS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE
CY1121188T1 (en) AMIDE-SUBSTITUTED HETEROCYCLE COMPOUNDS USED AS MODELERS OF IL-12, IL-23 AND IFN-ALFA RESPONSES
CY1116958T1 (en) Substituted triazolopyridines and their use as TKP inhibitors
CY1115945T1 (en) PYRAZOLOKINOLINONE PRODUCTS, THEIR PREPARATION AND THEIR THERAPEUTIC USE
CY1119387T1 (en) TRIAZOLOPYRAZINS AS BRD4 INHIBITORS FOR USE IN CANCER TREATMENT
CY1115585T1 (en) Crystalline Forms of 5-Amino-2,3-Dihydrophthalazine-1,4-Dione Sodium Salt, Which Contain Pharmaceutical Forms
CY1121804T1 (en) NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR USE
CY1118061T1 (en) HETEROCYCLYL BICYCLE DERIVATIVES AS KINASE FGFR FOR THERAPEUTIC USE
CY1115301T1 (en) ISOXAZOLIS PRODUCTS AND THEIR USE AS TRANSITIONAL GLUTAMIC CONTAINERS
CY1119015T1 (en) 4'-AZID-3'FLUORABLE NUCLEOZIDE SUBSTITUTES PRODUCER AS HCV RNA COPYPRISES
CY1115861T1 (en) METHYL CLEANING METHYL- {4,6-DIAMINO-2- [1- (2-fluorobenzyl) -1H-pyrazolo [3,4-B] pyridin-3-yl] pyrimidin-5-yl} Methyl
CY1117197T1 (en) TRIAZOLOPYRIDINE COMPOUNDS AS RIM kinase inhibitors
CY1113282T1 (en) ANTIQUE NUCLEOZITIC ANALOGS
CY1120460T1 (en) PYRAZOLOPYRIMIDINE PRODUCT WITH SUBSTITUTE 4 SUBSTITUTE, AND USE FOR PREPARATION OF MEDICINAL PRODUCTS
CO7141456A2 (en) Aril-sultamo derivatives as rorc modulators
CY1116150T1 (en) OXADIASOL PRODUCTS AND THEIR USE AS GLUTAMIC TRANSITIONAL RECEPTORS - 842
CY1110962T1 (en) Tricyclic compounds and their use as glucocorticoid receptor modulators
CY1116439T1 (en) Triazolopyridines
CY1115043T1 (en) pharmaceutical product
CY1116120T1 (en) Imidazopyrimidine or imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors
NI201200191A (en) INDOLIZINE DERIVATIVES, ITS PREPARATION PROCEDURE AND ITS APPLICATION IN THERAPEUTICS
BR112012029647A2 (en) new pyrimidine derivatives